40
December 2010
Singapore facility will Manufacture Mass Spectrometry Instruments to meet strong worldwide demand
Agilent Technologies announce the opening of its new life sciences instruments manufacturing facility in Singapore. The facility will produce the company’s Liquid Chromatography/Mass Spectrometry (LC/MS) instruments for the global market.
“The opening of the LC/MS manufacturing facility marks a milestone in Agilent’s continued investment in Singapore, which began in 1970,” said Bill Sullivan, Agilent president and CEO. “Singapore is the ideal location for this facility as it will provide us with greater access to the life sciences instrument market in Asia. The new facility also will bring us closer to our customers, as the pharmaceutical and biopharmaceutical industries have become an important part of Singapore’s overall economy and investment strategy.”
Agilent’s LC/MS instruments are widely used by pharmaceutical companies, from basic research through manufacturing and quality control. The instruments also serve customers in biotechnology, bioagriculture, food safety, chemical, petrochemical, forensics, homeland security, environmental, academic and government markets.
“This expansion marks a major achievement and positions Agilent to better meet rising worldwide customer demand for LC/MS instruments,” said Nick Roelofs, president of Agilent’s Life Sciences Group. “The new facility reflects the company’s commitment to Singapore, its partners, and other stakeholders in the Asia Pacific region, as well as to the growing life sciences market worldwide.”
UHPLC performance for separation of peptides HALO®
Peptide ES- C18 is a new HPLC column from
Advanced Materials Technology,
specifically designed for ultra-fast and ultra- high resolution separations of peptides up to 20kDa. Sterically-protected C18 ligands
In June 2009, the company announced the Agilent Automation Solutions facility, also in Singapore. The facility manufactures high-precision laboratory automation instruments.
“The new Agilent LC/MS manufacturing facility will attract top talent and enable the development of skilled engineers and chemists in Singapore as these are sophisticated high-end scientific instruments,” said Soon-Chai Gooi, president of Agilent Technologies, Singapore and Malaysia. “The facility builds on Agilent Singapore’s 40 years of innovation, experience and relationships with our partners and customers.”
For more information visit
www.agilent.com
provide extra stability, thus inhibiting acid hydrolysis of siloxane bonds with the low pH mobile phases and higher temperatures typically used for reproducible peptide separations.
As for all HALO® columns, Peptide ES-C18
columns contain advanced Fused-Core® particles, consisting of a solid core of 1.7µm with a 0.5µm porous outer shell. However, HALO Peptide ES-C18 particles have larger pores (160Å) than standard HALO particles (90Å). HALO Peptide ES-C18 columns have
low-bleed for LC/MS compatibility and excellent temperature (up to 90°C) and pH (1-8) stability.
These Fused-Core® particles generate
significantly lower back pressure compared to other UHPLC columns, enabling them to be used with conventional HPLC as well as UHPLC equipment.
HALO®
columns are also available as C18, C8, HILIC, RP-Amide and Phenyl-Hexyl phases.
For further information e-mail us at
technical@hichrom.co.uk
To view past issues or the latest news online please visit
www.chromatographytoday.com
If you would like to be included please email your details to
marcus@intlabmate.com or call us on: +44 (0)1727 855574
Produced in association with the Chromatography Society
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48
